183 related articles for article (PubMed ID: 23588726)
1. Specificity of squamous cell carcinoma antigen (SCCA)-IgM detection in patients with HCV infection and rheumatoid factor seropositivity.
Biasiolo A; Tono N; Zaninotto M; Merkel C; Fassina G; Plebani M; Gatta A; Pontisso P
J Med Virol; 2013 Jun; 85(6):1005-8. PubMed ID: 23588726
[TBL] [Abstract][Full Text] [Related]
2. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma.
Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G
Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222
[TBL] [Abstract][Full Text] [Related]
3. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis.
Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L
Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440
[TBL] [Abstract][Full Text] [Related]
4. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis.
Biasiolo A; Chemello L; Quarta S; Cavalletto L; Bortolotti F; Caberlotto C; Beneduce L; Bernardinello E; Tono N; Fassina G; Gatta A; Pontisso P
J Viral Hepat; 2008 Apr; 15(4):246-9. PubMed ID: 18248333
[TBL] [Abstract][Full Text] [Related]
5. Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients.
Bui Huu H; Ha Thuc N; Thi Le HP; Thi Thanh TD; Luong Bac A; Tiribelli C; Pontisso P; Gallotta A; Paneghetti L; Fassina G
Scand J Clin Lab Invest; 2018 May; 78(3):204-210. PubMed ID: 29381084
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC).
Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F
J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
Montagnana M; Danese E; Lippi G
Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
[TBL] [Abstract][Full Text] [Related]
10. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma.
Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L
Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605
[TBL] [Abstract][Full Text] [Related]
11. IgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver disease.
Biasiolo A; Tono N; Ruvoletto M; Quarta S; Turato C; Villano G; Beneduce L; Fassina G; Merkel C; Gatta A; Pontisso P
PLoS One; 2012; 7(7):e40658. PubMed ID: 22808225
[TBL] [Abstract][Full Text] [Related]
12. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.
Martini A; Fattovich G; Guido M; Bugianesi E; Biasiolo A; Ieluzzi D; Gallotta A; Fassina G; Merkel C; Gatta A; Negro F; Pontisso P
J Viral Hepat; 2015 Oct; 22(10):800-8. PubMed ID: 25611978
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of SCCA and SCCA-IgM for hepatocellular carcinoma: A meta-analysis.
Liu CH; Gil-Gómez A; Ampuero J; Romero-Gómez M
Liver Int; 2018 Oct; 38(10):1820-1831. PubMed ID: 29704434
[TBL] [Abstract][Full Text] [Related]
14. Serum Squamous Cell Carcinoma Antigen-Immunoglobulin M complex levels predict survival in patients with cirrhosis.
Cagnin M; Biasiolo A; Martini A; Ruvoletto M; Quarta S; Fasolato S; Angeli P; Fassina G; Pontisso P
Sci Rep; 2019 Dec; 9(1):20126. PubMed ID: 31882893
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study.
Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P
Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642
[TBL] [Abstract][Full Text] [Related]
16. Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.
Beneduce L; Pesce G; Gallotta A; Zampieri F; Biasiolo A; Tono N; Boscato N; Gatta A; Pontisso P; Fassina G
Eur J Clin Invest; 2008 Aug; 38(8):571-7. PubMed ID: 18625005
[TBL] [Abstract][Full Text] [Related]
17. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.
Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F
Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis.
Yu J; Wang ZJ; Chen LH; Dong WZ
Scand J Clin Lab Invest; 2017 Feb; 77(1):8-14. PubMed ID: 27762143
[TBL] [Abstract][Full Text] [Related]
19. [Surveillance of cirrhosis for hepatocellular carcinoma--clinical validation of new serological biomarkers for improved diagnosis].
Teofănescu I; Gologan E; Stefănescu G; Bălan G
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):39-46. PubMed ID: 20509274
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease.
Turato C; Ruvoletto MG; Biasiolo A; Quarta S; Tono N; Bernardinello E; Beneduce L; Fassina G; Cavalletto L; Chemello L; Merkel C; Gatta A; Pontisso P
Dig Liver Dis; 2009 Mar; 41(3):212-6. PubMed ID: 18657489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
